The Chief Executive Officer and member of the Board of Directors of Achieve Life Sciences is Dr. Andrew D. Goldberg. A trained physician and experienced healthcare investor, Dr. Goldberg directs the clinical advancement and regulatory strategy of the company's smoking cessation and nicotine dependence therapeutic pipeline.